The FDA requested that Novo take immediate action to address the violations, which could include ceasing all ads containing ...

GoodRx reports that the FDA has approved oral semaglutide (Wegovy) for weight loss, offering an alternative to injections with similar results.

Patients wishing for an alternative to weight loss drug injections now have another option. The U.S. Food and Drug ...

‘It’s not an easy pill to take’: The first highly anticipated GLP-1 pill is here, but physicians aren’t sure it has the staying power of the injections ...

In coming weeks, Wegovy pill will be available in four doses: a starter dose of 1.5 mg, as well as 4 mg, 9 mg, and 25 mg. As ...

Telehealth company Hims & Hers dropped its plan to offer a knockoff version of the weight-loss pill Wegovy on Saturday — two days after it announced the new drug.

Novo continues to battle increased compounding of its drugs, in spite of semaglutide shortage having been resolved. ・Doustdar dismissed competition concerns with rival drugmaker Eli Lilly on Friday, ...

It’s still experimental but the pill helps rid the body of cholesterol in a way that today can be done only with injected ...

Hims & Hers caused a firestorm last week when it revealed that it planned to launch a knockoff version of Novo Nordisk's new ...

An experimental pill called enlicitide was found to dramatically lower LDL (“bad”) cholesterol by ~60% in a large phase 3 clinical trial. The study ...

A new drug capsule can help large proteins such as insulin and small-molecule drugs be absorbed in the digestive tract. The capsule has a robotic cap that spins and tunnels through the mucus barrier ...

Feb 9 (Reuters) - The U.S. Food and Drug Administration said a television advertisement for Novo Nordisk's weight-loss pill ...